Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors

WR Tracey, J Tse and G Carter

Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois.

The benefits of nitric oxide synthase (NOS) inhibitors in the treatment of endotoxemia or sepsis presumably arise from inhibition of the type II (inducible) NOS. However, inasmuch as the effect of these inhibitors on NOS function in vivo is rarely assessed, NOS activity was evaluated in rats and mice by measuring changes in plasma nitrite and nitrate concentrations ([NOx]) after administration of lipopolysaccharide (LPS). In both species, [NOx] peaked at 20 hr, returning to base line by 48 to 72 hr. The ED50 values (dose that elicited a 50% inhibition of the LPS-dependent increase in [NOx] 6 hr after LPS administration) for L-NG-monomethylarginine acetate, L-NG-nitroarginine methyl ester and aminoguanidine (administered 3 hr after LPS) were 34, 21 and 19 mg/kg in the rat and 32, 5 and 4 mg/kg in the mouse. These compounds also decreased the survival of LPS-challenged animals, which in the case of L-NG-nitroarginine methyl ester was reversed by L-arginine. Dexamethasone (which prevents the induction of type II NOS) also inhibited the LPS-dependent increase in [NOx] with ED50 values of 0.05 mg/kg (rat) and 1 mg/kg (mouse), but did not lead to decreased survival. Thus, inhibition of the type I (neuronal) or type III (endothelial) NOS, rather than the type II isoform, may be a possible mechanism for the animal mortality. These models provide a simple and reproducible means for assessing the in vivo inhibition of type II NOS by various compounds.

Volume 272, Issue 3, pp. 1011-1015, 03/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J. Bultinck, P. Sips, L. Vakaet, P. Brouckaert, and A. Cauwels Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock FASEB J, November 1, 2006; 20(13): 2363 - 2365. [Abstract] [Full Text] [PDF]

				M. D. Lehner, D. Marx, R. Boer, A. Strub, C. Hesslinger, M. Eltze, W.-R. Ulrich, F. Schwoebel, R. T. Schermuly, and J. Barsig In Vivo Characterization of the Novel Imidazopyridine BYK191023 [2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine], a Potent and Highly Selective Inhibitor of Inducible Nitric-Oxide Synthase J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 181 - 187. [Abstract] [Full Text] [PDF]

				M. Endo, S. Oyadomari, M. Suga, M. Mori, and T. Gotoh The ER Stress Pathway Involving CHOP Is Activated in the Lungs of LPS-Treated Mice J. Biochem., October 1, 2005; 138(4): 501 - 507. [Abstract] [Full Text] [PDF]

				D.-X. Xu, Y.-H. Chen, J.-P. Wang, M.-F. Sun, H. Wang, L.-Z. Wei, and W. Wei Perinatal Lipopolysaccharide Exposure Downregulates Pregnane X Receptor and Cyp3a11 Expression in Fetal Mouse Liver Toxicol. Sci., September 1, 2005; 87(1): 38 - 45. [Abstract] [Full Text] [PDF]

				T. H. Elsasser, S. Kahl, C. MacLeod, B. Nicholson, J. L. Sartin, and C. Li Mechanisms Underlying Growth Hormone Effects in Augmenting Nitric Oxide Production and Protein Tyrosine Nitration during Endotoxin Challenge Endocrinology, July 1, 2004; 145(7): 3413 - 3423. [Abstract] [Full Text] [PDF]

				E. Tiravanti, A. Samouilov, and J. L. Zweier Nitrosyl-Heme Complexes Are Formed in the Ischemic Heart: EVIDENCE OF NITRITE-DERIVED NITRIC OXIDE FORMATION, STORAGE, AND SIGNALING IN POST-ISCHEMIC TISSUES J. Biol. Chem., March 19, 2004; 279(12): 11065 - 11073. [Abstract] [Full Text] [PDF]

				J. A. Scott, S. Mehta, M. Duggan, A. Bihari, and D. G. McCormack Functional Inhibition of Constitutive Nitric Oxide Synthase in a Rat Model of Sepsis Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1426 - 1432. [Abstract] [Full Text] [PDF]

				Y. J. Kang, S. J. Seo, H. S. Yun-Choi, D. H. Lee, Y.-M. Kim, and K. C. Chang A Synthetic Isoquinoline Alkaloid, 1-(beta -Naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (YS 51), Reduces Inducible Nitric Oxide Synthase Expression and Improves Survival in a Rodent Model of Endotoxic Shock J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 561 - 567. [Abstract] [Full Text] [PDF]

				J. Pleiner, E. Heere-Ress, H. Langenberger, A. E. Sieder, M. Bayerle-Eder, F. Mittermayer, G. Fuchsjager-Mayrl, J. Bohm, B. Jansen, and M. Wolzt Adrenoceptor Hyporeactivity Is Responsible for Escherichia coli Endotoxin-Induced Acute Vascular Dysfunction in Humans Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 95 - 100. [Abstract] [Full Text] [PDF]

				Y. Devaux, C. Seguin, S. Grosjean, N. de Talance, V. Camaeti, A. Burlet, F. Zannad, C. Meistelman, P.-M. Mertes, and D. Longrois Lipopolysaccharide-Induced Increase of Prostaglandin E2 Is Mediated by Inducible Nitric Oxide Synthase Activation of the Constitutive Cyclooxygenase and Induction of Membrane-Associated Prostaglandin E Synthase J. Immunol., October 1, 2001; 167(7): 3962 - 3971. [Abstract] [Full Text] [PDF]

				Y. Devaux, C. Seguin, S. Grosjean, N. de Talance, M. Schwartz, A. Burlet, F. Zannad, C. Meistelman, P.-M. Mertes, and D. Ungureanu-Longrois Retinoic Acid and Lipopolysaccharide Act Synergistically to Increase Prostanoid Concentrations in Rats In Vivo J. Nutr., October 1, 2001; 131(10): 2628 - 2635. [Abstract] [Full Text] [PDF]

				R. M. Bateman, J. E. Jagger, M. D. Sharpe, M. L. Ellsworth, S. Mehta, and C. G. Ellis Erythrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2848 - H2856. [Abstract] [Full Text] [PDF]

				Y. Devaux, S. Grosjean, C. Seguin, C. David, B. Dousset, F. Zannad, C. Meistelman, N. De Talance, P.-M. Mertes, and D. Ungureanu-Longrois Retinoic acid and host-pathogen interactions: effects on inducible nitric oxide synthase in vivo Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1045 - E1053. [Abstract] [Full Text] [PDF]

				H. Ando, T. Takamura, T. Ota, Y. Nagai, and K.-i. Kobayashi Cerivastatin Improves Survival of Mice with Lipopolysaccharide-Induced Sepsis J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1043 - 1046. [Abstract] [Full Text]

				K. McMillan, M. Adler, D. S. Auld, J. J. Baldwin, E. Blasko, L. J. Browne, D. Chelsky, D. Davey, R. E. Dolle, K. A. Eagen, et al. Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry PNAS, February 15, 2000; 97(4): 1506 - 1511. [Abstract] [Full Text] [PDF]

				E. CRESPO, M. MACÍAS, D. POZO, G. ESCAMES, M. MARTÍN, F. VIVES, J. M. GUERRERO, and D. ACUÑA-CASTROVIEJO Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats FASEB J, September 1, 1999; 13(12): 1537 - 1546. [Abstract] [Full Text]

				K. R. WALLEY, T. E. MCDONALD, Y. HIGASHIMOTO, and S. HAYASHI Modulation of Proinflammatory Cytokines by Nitric Oxide in Murine Acute Lung Injury Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 698 - 704. [Abstract] [Full Text]

				A. C. Sharma, B. G. Fogelson, S. I. Nawas, W. T. Vigneswaran, A. D. Sam II, K. J. Alden, J. L. Ferguson, and W. R. Law Elevated coronary endothelin-1 but not Nitric Oxide in diabetics during CABG Ann. Thorac. Surg., June 1, 1999; 67(6): 1659 - 1663. [Abstract] [Full Text] [PDF]

				B. Särnstrand, A.-H. Jansson, G. Matuseviciene, A. Scheynius, S. Pierrou, and H. Bergstrand N,N'-Diacetyl-L-cystine---the Disulfide Dimer of N-acetylcysteine---Is a Potent Modulator of Contact Sensitivity/Delayed Type Hypersensitivity Reactions in Rodents J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1174 - 1184. [Abstract] [Full Text]

				D. T. Lysle and T. How Endogenous Opioids Regulate the Expression of Inducible Nitric Oxide Synthase by Splenocytes J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 502 - 508. [Abstract] [Full Text]

				S. Sethi, M. P. Singh, and M. Dikshit Nitric Oxide-Mediated Augmentation of Polymorphonuclear Free Radical Generation After Hypoxia-Reoxygenation Blood, January 1, 1999; 93(1): 333 - 340. [Abstract] [Full Text] [PDF]

				M. B. Sewer and E. T. Morgan Down-Regulation of the Expression of Three Major Rat Liver Cytochrome P450S by Endotoxin In Vivo Occurs Independently of Nitric Oxide Production J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 352 - 358. [Abstract] [Full Text]

				M. B. Sewer, T. B. Barclay, and E. T. Morgan Down-Regulation of Cytochrome P450 mRNAs and Proteins in Mice Lacking a Functional NOS2 Gene Mol. Pharmacol., August 1, 1998; 54(2): 273 - 279. [Abstract] [Full Text]

				D. S. Fletcher, W. R. Widmer, S. Luell, A. Christen, C. Orevillo, S. Shah, and D. Visco Therapeutic Administration of a Selective Inhibitor of Nitric Oxide Synthase Does Not Ameliorate the Chronic Inflammation and Tissue Damage Associated with Adjuvant-Induced Arthritis in Rats J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 714 - 721. [Abstract] [Full Text]

				L. S. Feder, D. Stelts, R. W. Chapman, D. Manfra, Y. Crawley, H. Jones, M. Minnicozzi, X. Fernandez, T. Paster, R. W. Egan, et al. Role of Nitric Oxide on Eosinophilic Lung Inflammation in Allergic Mice Am. J. Respir. Cell Mol. Biol., October 1, 1997; 17(4): 436 - 442. [Abstract] [Full Text]

				P. Villa, C. Meazza, M. Sironi, M. Bianchi, P. Ulrich, G. Botchkina, K.J. Tracey, and P. Ghezzi Protection against lethal polymicrobial sepsis by CNI-1493, an inhibitor of pro-inflammatory cytokine synthesis Innate Immunity, June 1, 1997; 4(3): 197 - 204. [Abstract] [PDF]

				O. Khatsenko and Y. Kikkawa Nitric Oxide Differentially Affects Constitutive Cytochrome P450 Isoforms in Rat Liver J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1463 - 1470. [Abstract] [Full Text]

				A. ROSSELET, F. FEIHL, M. MARKERT, A. GNAEGI, C. PERRET, and L. LIAUDET Selective iNOS Inhibition Is Superior to Norepinephrine in the Treatment of Rat Endotoxic Shock Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 162 - 170. [Abstract] [Full Text]